THOMAS G. WIGGANS - 01 Nov 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
4
Filing time
02 Nov 2023, 18:00:55 UTC
Previous filing
31 Aug 2023
Next filing
20 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +110,000 $0.000000 110,000 01 Nov 2023 Voting Common Stock 110,000 $0.6900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on November 1, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.